<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BF812935-3523-4542-8B74-C43165CBCA00"><gtr:id>BF812935-3523-4542-8B74-C43165CBCA00</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Howell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/982456DE-E06B-465F-9F39-CA4B2019B9A7"><gtr:id>982456DE-E06B-465F-9F39-CA4B2019B9A7</gtr:id><gtr:firstName>Reza Sarvghad</gtr:firstName><gtr:surname>Razavi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D755320B-897A-4664-984C-1480D6978A96"><gtr:id>D755320B-897A-4664-984C-1480D6978A96</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Lechler</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8A5588FD-8AA4-43CC-9746-E20B08CF6AA0"><gtr:id>8A5588FD-8AA4-43CC-9746-E20B08CF6AA0</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Foulkes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15031"><gtr:id>0A34B6A1-970E-4326-B2CD-C7FF331D929B</gtr:id><gtr:title>King?s College London Confidence in Concept</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15031</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Confidence in Concept scheme is a key part of MRC?s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach ?? before seeking more substantive funding.&amp;nbsp; It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.</gtr:technicalSummary><gtr:fund><gtr:end>2018-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>750000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Els</gtr:description><gtr:id>EB4B22B9-A41E-40DF-9ED8-8A13960B7771</gtr:id><gtr:impact>Provides expert advice on genetic manipulation of stem cells</gtr:impact><gtr:outcomeId>58bd3e67aaf703.26540177-1</gtr:outcomeId><gtr:partnerContribution>Provides expert advice</gtr:partnerContribution><gtr:piContribution>Perform experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Tetramer</gtr:description><gtr:id>5922F2F7-1F15-43E8-9DB7-0492B66B0133</gtr:id><gtr:impact>The reagents provided by NIH are necessary for the progress and development of the research project</gtr:impact><gtr:outcomeId>54537bce16dcb3.34803436-1</gtr:outcomeId><gtr:partnerContribution>Provide unique reagents required for the project</gtr:partnerContribution><gtr:piContribution>We will use the reagents provided for the development of the research project</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Systems biomedicine graduate programme</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F91F587D-DBAD-4C49-8043-6B1C7782ABDA</gtr:id><gtr:impact>An annual series of lectures on a wide variety of biomedical topics, for a multidisciplinary audience of postgraduate students. The aim is to break down barriers between the biomedical and the mathematical/physical sciences, and encourage young scientists to engage in multidisciplinary research.</gtr:impact><gtr:outcomeId>58c83c84adcc27.36215709</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Towards a theory of overfitting in proportional hazards regression for survival data</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>570A1CB6-E04E-49D7-A0FB-95E959C98D3A</gtr:id><gtr:impact>Invited research seminar at the Department of Statistics of Columbia University (New York, USA)</gtr:impact><gtr:outcomeId>58c8398d86bc20.16440336</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://nms.kcl.ac.uk/ton.coolen/seminars/NYC2016.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How can we bond and repair carious dentine?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0291EF72-9055-409C-A554-329EF963E658</gtr:id><gtr:impact>Keynote presentation at the International Association for Dental Research General Session in San Francisco</gtr:impact><gtr:outcomeId>58c90ba53a6294.39316513</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>What data bases and statistics do we need? Meeting the challenges of data-driven precision medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>44A74EC3-FE04-4E00-AE92-117B7A4D8281</gtr:id><gtr:impact>Invited talk for the annual meeting of the German Opthamological Society (Berlin)</gtr:impact><gtr:outcomeId>58c83a41424127.55456520</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Give me six hours to chop down a tree ... statistical tools to meet the challenges of modern medical data</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>37A1EA51-BE32-4A88-8531-6AA9D030B1F8</gtr:id><gtr:impact>Invited seminar at the Mayo Clinic (Rochester, USA)</gtr:impact><gtr:outcomeId>58c83902c4cce5.01378971</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://nms.kcl.ac.uk/ton.coolen/seminars/Mayo2016.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>46667</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>King's Health Partners Challenge Fund</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>King?s Health Partners</gtr:fundingOrg><gtr:fundingRef>R160405</gtr:fundingRef><gtr:id>F66CE493-B50E-474A-9BE1-67A67CC80CA6</gtr:id><gtr:outcomeId>586e49c552d2a9.29732366</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>detection of early stage heart failure</gtr:description><gtr:grantRef>MC_PC_15031</gtr:grantRef><gtr:id>087A9222-3AA7-4A55-AB09-BF4903C5EAED</gtr:id><gtr:impact>None yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b82a2b61ad78.60564573</gtr:outcomeId><gtr:patentId>GB1603216.1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Measurement of cardiac first phase ejection fraction</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BF98835D-739F-4E36-9737-75E9EA138CDF</gtr:id><gtr:title>Investigating a Novel Activation-Repolarisation Time Metric to Predict Localised Vulnerability to Reentry Using Computational Modelling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b3a0b37f1af2a8d71af67e4a2622d3"><gtr:id>56b3a0b37f1af2a8d71af67e4a2622d3</gtr:id><gtr:otherNames>Hill YR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d94a6922cf38.71511677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54188209-CE8A-4ED5-B597-ED6810C893DB</gtr:id><gtr:title>Computational Representations of Myocardial Infarct Scars and Implications for Arrhythmogenesis.</gtr:title><gtr:parentPublicationTitle>Clinical Medicine Insights. Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d0b39f6eec3e204a8c95f2bb220d952"><gtr:id>4d0b39f6eec3e204a8c95f2bb220d952</gtr:id><gtr:otherNames>Connolly AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1179-5468</gtr:issn><gtr:outcomeId>58c6b8abec9646.77552319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E82E920-BFA8-450E-92FA-2DE0CC818A27</gtr:id><gtr:title>Reduced First-Phase Ejection Fraction and Sustained Myocardial Wall Stress in Hypertensive Patients With Diastolic Dysfunction: A Manifestation of Impaired Shortening Deactivation That Links Systolic to Diastolic Dysfunction and Preserves Systolic Ejection Fraction.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5520173dc08b4981a1ca8edcf89bb74f"><gtr:id>5520173dc08b4981a1ca8edcf89bb74f</gtr:id><gtr:otherNames>Gu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>58c8377f0e0af9.23672876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55E5A996-DB6C-4988-A518-D0B90CBF4017</gtr:id><gtr:title>Voxel-wise comparisons of cellular microstructure and diffusion-MRI in mouse hippocampus using 3D Bridging of Optically-clear histology with Neuroimaging Data (3D-BOND).</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d118f9d9b25fde9a2293d1cff6c80716"><gtr:id>d118f9d9b25fde9a2293d1cff6c80716</gtr:id><gtr:otherNames>Stolp HB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa3cc3fae9560.47616399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A7E3BA4-617F-4A75-B651-F23E330D7BF4</gtr:id><gtr:title>Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/722c4ac63ded662dc422a0a61495e934"><gtr:id>722c4ac63ded662dc422a0a61495e934</gtr:id><gtr:otherNames>Manook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>58ae98a89ee3c1.38127672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15EE3C08-74EE-4E53-92E7-DCE729FECBA2</gtr:id><gtr:title>Transitional B cell subsets-a convincing predictive biomarker for allograft loss?</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e103252a8160e7ff2d72b21e4bef1aae"><gtr:id>e103252a8160e7ff2d72b21e4bef1aae</gtr:id><gtr:otherNames>Burton H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>586b691120f107.73487298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE76A410-9128-47A9-A16E-97E0DD95F9DA</gtr:id><gtr:title>HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cfa086286fe6e5a13fbeea65bfebb5a"><gtr:id>7cfa086286fe6e5a13fbeea65bfebb5a</gtr:id><gtr:otherNames>Weitsman G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c82ba27c4e19.66495292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54D46205-0B7A-4C9F-B80F-84A4C16C023F</gtr:id><gtr:title>Structural lipids enable the formation of functional oligomers of the eukaryotic purine symporter UapA</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90a086c829a334e7e83fcc36c831b90e"><gtr:id>90a086c829a334e7e83fcc36c831b90e</gtr:id><gtr:otherNames>Pyle E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa15dc5c72a0.41600065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3014C6BA-0096-4576-9DFA-48DA485DFCFF</gtr:id><gtr:title>Mitochondrial dynamics, mitophagy and biogenesis in neonatal hypoxic-ischaemic brain injury.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6185a4a5d55e828ce4e37c51d706e0b"><gtr:id>c6185a4a5d55e828ce4e37c51d706e0b</gtr:id><gtr:otherNames>Thornton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>5a678dfea24f34.93594799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECF573E3-C187-40DC-9330-20BD475F6158</gtr:id><gtr:title>Regulation of Reactionary Dentine Formation.</gtr:title><gtr:parentPublicationTitle>Journal of dental research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bb0c5480c479f7b22f47bba28b445f3"><gtr:id>7bb0c5480c479f7b22f47bba28b445f3</gtr:id><gtr:otherNames>Neves VCM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-0345</gtr:issn><gtr:outcomeId>5a7d663bd79834.07239550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BFBE504-62DB-469F-A54C-7D992A01D339</gtr:id><gtr:title>Axin2-expressing cells differentiate into reparative odontoblasts via autocrine Wnt/?-catenin signaling in response to tooth damage.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83ca40246b3b08d2e199e006af33166c"><gtr:id>83ca40246b3b08d2e199e006af33166c</gtr:id><gtr:otherNames>Babb R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a7d6611db1321.45231141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65382BA9-8495-43ED-AFA4-EB83E85FF233</gtr:id><gtr:title>Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-? production by Th1 cells.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25ee74e60fac27a1dbf2c03b22f0cff8"><gtr:id>25ee74e60fac27a1dbf2c03b22f0cff8</gtr:id><gtr:otherNames>Shiu KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>586b6910df7834.06699112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>296A1495-AE4E-4BD8-9A8E-72369FFE571B</gtr:id><gtr:title>Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/722c4ac63ded662dc422a0a61495e934"><gtr:id>722c4ac63ded662dc422a0a61495e934</gtr:id><gtr:otherNames>Manook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5874a8c48cefe4.59676050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0975368-A112-402E-80FC-D466757488AF</gtr:id><gtr:title>Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d38533440d766f656401f3cb7d2053"><gtr:id>c2d38533440d766f656401f3cb7d2053</gtr:id><gtr:otherNames>Rowley MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c82a209c6057.24650489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61552AA0-1C38-4165-882E-ED73188034E3</gtr:id><gtr:title>AMPK: keeping the (power)house in order?</gtr:title><gtr:parentPublicationTitle>Neuronal Signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6185a4a5d55e828ce4e37c51d706e0b"><gtr:id>c6185a4a5d55e828ce4e37c51d706e0b</gtr:id><gtr:otherNames>Thornton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c2d98eaddf31.06394684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E71205CD-0804-4ABA-ACE9-20E56F160FF5</gtr:id><gtr:title>Image-Based Personalization of Cardiac Anatomy for Coupled Electromechanical Modeling.</gtr:title><gtr:parentPublicationTitle>Annals of biomedical engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8781fbcc94606007a459f6aeb055b06d"><gtr:id>8781fbcc94606007a459f6aeb055b06d</gtr:id><gtr:otherNames>Crozier A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0090-6964</gtr:issn><gtr:outcomeId>56cae3e064af23.56260993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48F1E036-AA59-4772-A506-18FF215737D6</gtr:id><gtr:title>Specific cardiolipin-SecY interactions are required for proton-motive-force stimulation of protein secretion</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5868c9eebcc7e56e1278ffba3d4fe8aa"><gtr:id>5868c9eebcc7e56e1278ffba3d4fe8aa</gtr:id><gtr:otherNames>Corey R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa16254ed887.88162231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C54F6C68-6F7D-42B5-9ADF-291C461FE504</gtr:id><gtr:title>A latent class model for competing risks.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3f635227235368a6d95ec60e82e30b9"><gtr:id>f3f635227235368a6d95ec60e82e30b9</gtr:id><gtr:otherNames>Rowley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>58c828150cda26.24795336</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15031</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>